Fed Circuit Watch: Personalized Medicine Method Claim Passes Alice Test for Subject Matter Eligibility

101 fed circuit watch patent patent eligible subject matter

This case, Vanda Pharmaceuticals Inc. v. West-Ward Pharmaceuticals Int’l Ltd.,[1] arrived to the appeals court through an unusual, but not uncommon, route: a 35 U.S.C. §271(e)(4)(A) infringement resulting from a 21 U.S.C. §355(j) application, or the Abbreviated New Drug Application (ANDA) (aka, generic drug approval process).  However, the other aspect of this case is that …

Continue Reading

Fed Circuit Watch: Knowles Déjà Vu as PTAB Not (Necessarily) Bound to Prior Court Claim Construction

fed circuit watch patent PTAB

In a case of déjà vu, the Court of Appeals for the Federal Circuit handed down Knowles Electronics LLC v. Iancu,[1] on April 6, 2018.  This case bears striking resemblance to an earlier-issued case this term, Knowles Electronics LLC v. Cirrus Logic, Inc., of which the issues were previously discussed on this blog.  The panels …

Continue Reading

Fed Circuit Watch: No Overlap Required for Prima Facie Obviousness Between Claimed & Prior Art Ranges

103 fed circuit watch obviousness patent

On March 27, 2018, the Court of Appeals for the Federal Circuit ruled in In re Brandt, which is just another case in a long line of cases dealing with ranges and obviousness under 35 U.S.C. §103.  The facts are as follows. Gregory A. Brandt and John B. Letts, the application-at-issue’s two inventors, and Firestone …

Continue Reading

Fed Circuit Watch: Unreasonably Broad PTAB Claim Construction Reversed

102 BRI fed circuit watch patent

On March 19, 2018, the Court of Appeals for the Federal Circuit rejected, in In re Power Integrations, Inc.,[1] a PTAB decision finding that claims were invalidated as anticipated as unreasonably overbroad.  The claim construction was subject in an ex parte reexamination of Power Integrations’ U.S. Patent No. 6,249,876 (‘876).  ‘876 is directed to “Frequency …

Continue Reading

Fed Circuit Watch: Written Description From Earlier-Filed PCT with Species Claim Sufficient Support for Later-Filed Genus Claim

102 112 fed circuit watch patent PCT pre-AIA priority Written Description

On March 14, 2018, the Court of Appeals for the Federal Circuit ruled on Hologic, Inc. v. Smith & Nephew, Inc.,[1] which deals with many areas in patents, including foreign applications, priority claims, 35 U.S.C. §103, 35 U.S.C. §112, and pre-AIA treatment for examination.  This case was heard before a panel composing of Judges Newman, …

Continue Reading

Fed Circuit Watch: Well-Prepared Lexicography Dooms Claim Term as Obvious

103 BRI fed circuit watch IPR lexicography patent

This, unfortunately, was a bad week for Steuben Foods, Inc., since this is the second case it lost at the Federal Circuit against the same adversary, Nestlé Foods.  This time, in Nestle USA, Inc. v. Steuben Foods, Inc.,[1] the Court of Appeals for the Federal Circuit, on March 13, 2018, ruled that Steuben Foods could …

Continue Reading

Fed Circuit Watch: Claim Construction in Earlier IPR Bars Review of Same Term in Later IPR

collateral estoppel fed circuit watch IPR patent

Steuben Foods, Inc. did not have a good week at the Federal Circuit.  On March 13, 2018, two decisions were rendered against it in two patent cases, although for different rationales.  The first, Nestlé USA, Inc. v. Steuben Foods, Inc.,[1] the Court of Appeals for the Federal Circuit ruled that Steuben Foods could not argue …

Continue Reading